Navigation Links
Clarus Ventures Names Two New Partners
Date:1/5/2009

Dr. Emmett Cunningham and Scott Requadt Promoted From Principals

CAMBRIDGE, Mass., and SOUTH SAN FRANCISCO, Calif., Jan. 5 /PRNewswire/ -- Clarus Ventures, LLC ("Clarus Ventures"), a leading life sciences venture capital firm, announced today the promotions of Emmett Cunningham, M.D., Ph.D., M.P.H., to Partner and Scott Requadt, J.D., M.B.A., to Transactional Partner, effective Jan. 1, 2009.

Dr. Cunningham joined Clarus in 2006 and represents the firm as a Director on the Board of SARcode and as a Board Observer at FerroKin, Pearl, Taligen and Zogenix. He is also a member of the Scientific Advisory Boards of ESBATech and CoMentis. Dr. Cunningham joined Clarus from Eyetech Pharmaceuticals, where he was Senior Vice President of Medical Strategy and helped build and lead the development and commercialization of Macugen, a first-in-class product for the treatment of age-related macular degeneration. Prior to Eyetech, Dr. Cunningham was at Pfizer, where he was responsible for the clinical development of early-phase CNS compounds and the in-licensing of early- and late-stage therapeutic candidates in ophthalmology.

In addition to his extensive clinical, scientific and operating experience in the pharmaceutical, biotech and medtech industries, Dr. Cunningham is an internationally recognized specialist in eye diseases with more than 200 publications. In addition to his investing responsibilities at Clarus, he is an Adjunct Clinical Professor of Ophthalmology at Stanford. Dr. Cunningham received his M.D. and M.P.H. degrees from Johns Hopkins University and his Ph.D. degree in neuroscience from the University of California at San Diego. He completed his residency in ophthalmology and his fellowship training in corneal disease and uveitis at the University of California, San Francisco.

"Emmett has demonstrated a superior understanding of a wide
'/>"/>

SOURCE Clarus Ventures, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Clarus Ventures Closes $660 Million Fund
2. Hank Plain Joins Morgenthaler Ventures as Partner
3. Dan Broderick Joins Prolog Ventures as Partner
4. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
5. Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
6. Khosla Ventures and BIOeCON Form KiOR Inc.
7. Jerusalem Global Ventures Announces $200 Million Growth Equity Fund
8. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
9. The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.
10. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
11. SPO Medical Retains American Capital Ventures for Investor Relations Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015 As part of its ... (BDWMC), Sun Health Foundation funded a $3.25 million project ... pharmacy with the most up-to-date features and technology. , ... The pharmacy's 45 staff members will begin moving from ... in the coming days. , The current pharmacy ...
(Date:5/21/2015)... 2015 Veolia’s environmental monitoring technology ... American distribution agreement with VWR to distribute TECTA™ ... more than 160 years of experience, VWR, a ... laboratory and production facilities, has cultivated a value ... services to enable science. Endetec’s TECTA™ B16, ...
(Date:5/20/2015)... 20, 2015 Research and Markets ( ... "Top Technologies in HW_Technical Insights" report to their ... evaluated technology trends in the Health and Wellness sector ... to have an impact in the year 2015. The ... top 10 health and wellness technologies that are anticipated ...
(Date:5/20/2015)... , May 20, 2015  Select Medical Corporation ... Federal Trade Commission granted early termination of the ... Act of 1976, as amended, applicable to the ... Corporation, a joint venture that Select has created ... As previously announced, MJ Acquisition Corporation has ...
Breaking Biology Technology:Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 3Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Top Technologies in the Health and Wellness Industry 2015 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... 30 Sinovac Biotech Ltd. (NYSE Amex: ... in China, today announced that the Company has initiated ... the new influenza A (H1N1) strain, Swine Flu, which ... the world. Sinovac has contacted various Chinese government authorities ...
... Outside In" Program to Launch at the Annual Oncology Nursing ... (Nasdaq: AMGN ) and ONS Edge , a ... they will partner alongside celebrity make-up artist and cancer survivor ... with Cancer From the Outside In . The initiative is ...
... Tigris Pharmaceuticals, Inc., a privately held drug development company, ... molecule, AFP-464, during the recent AACR 100th Annual Meeting ... advancement in the treatment of Triple Negative Breast Cancer, ... cancer," stated Edmundo Muniz, M.D., Ph.D., President and Chief ...
Cached Biology Technology:Sinovac Initiates Preparatory Activities for Swine Flu Vaccine 2Sinovac Initiates Preparatory Activities for Swine Flu Vaccine 3Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 2Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 3Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 4Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 5Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 6Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 2Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 3Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 4
(Date:5/21/2015)... , May 21, 2015 ... Imaging Market by Solutions (Hardware, Software, Services), by Applications ... & others), by End-Users (Military & Defense & ... MarketsandMarkets, Thermal Imaging Market is expected to grow ... by 2020, at a Compound Annual Growth Rate ...
(Date:5/19/2015)... GOTHENBURG, Sweden , May 18, 2015 ... touch fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from ... place from June until and including Q3 2015 and the ... Asia . Communicated order values for 2015 hereby amount ... revenues for Q1 2015 of 140 MSEK and a number ...
(Date:5/14/2015)... May 14, 2015 Research and Markets ... "Fingerprint Sensors Market in Smart Mobile Devices " ... believes that 2014 was a watershed year for fingerprint ... of ,Apple Pay,. Apple gave fingerprint sensors a raison ... service. Fingerprint sensors are a must-have feature in flagship ...
Breaking Biology News(10 mins):Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
... Anthropogenic CO 2 emissions, in addition to causing ... them to turn progressively acidic. This change has severe ... in the latest edition of the journal Science ... of the Earth,s oceans has undergone profound changes, although none ...
... The American Cancer Society estimates that 44,000 new cases ... 37,000 people will die from the disease. These are not ... to rush through replication and then stops them cold, ... M phase. Healthy cells that don,t rush are unharmed. ...
... from Parkinson,s disease, a disorder of the nervous system ... world,s population ages, it,s estimated that the number of ... several effective therapies that treat Parkinson,s symptoms, nothing slows ... what exactly causes the disease, evidence points to one ...
Cached Biology News:Oceans acidifying faster today than in past 300 million years 2Tortoise and the hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed 2Parkinson's disease stopped in animal model 2Parkinson's disease stopped in animal model 3
B-FABP (FL-132)...
Roll of Mesh 5m x 25cm...
Oven mesh sheets, large, 23 x 23cm, pack of 5...
... Protein Phosphatase-2A (PPase-2A) is a serine/threonine phosphatase ... is isolated as the heterodimer of 60kDa ... the ability to dephosphorylate the a-subunit of ... PPase-2A has broad substrate specificity and may ...
Biology Products: